Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q3 2025 · 10-Q
Revenue$0.00$0.00— vs Q3 2024 Net Income-$310.15K-$310.15KN/M vs Q3 2024 EPS Diluted$0.00$0.00N/M vs Q3 2024 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
-$310,134
N/M
Operating Cash Flowderived-$359,056N/M ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end